IsoRay takes stake in Russian manufacturer

Medical isotope developer IsoRay has purchased a 30% ownership stake in Russian medical isotope manufacturing and distribution company UralDial.

The new company, based in Yekaterinburg, Russia, should significantly reduce IsoRay's manufacturing costs, will ensure a steady supply of isotopes from multiple Russian sources, and open new international markets for IsoRay's Proxcelan cesium-131 brachytherapy seeds, according to the Richland, WA-based firm.

Related Reading

IsoRay's cesium isotope used for eye cancer, December 13, 2007

IsoRay posts Q1 2008 results, November 9, 2007

IsoRay inks global alliance with Belgian firm, September 27, 2007

IsoRay expands new brachytherapy plant, August 30, 2007

IsoRay to join AMEX, April 16, 2007

Copyright © 2008 AuntMinnie.com

Page 1 of 1264
Next Page